SILVER SPRING, Md., Sept. 30 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced the availability of the first draft guidance for industry on Risk Evaluation and Mitigation Strategies or REMS, which are required for certain drugs or biologics.
The Food and Drug Administration Amendments Act of 2007 (FDAAA) granted the FDA the authority to require the submission and implementation of a REMS if the FDA determines a REMS is necessary to ensure that a drug's benefits outweigh its risks.
REMS components include medication guides; patient package inserts; a communication plan for health care providers; elements to ensure safe use including requirements for those who prescribe, dispense, or use the drug; and a timetable for REMS submission.
The draft guidance for industry titled "Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications":
- provides FDA's current thinking on the format and content that industry should use for submissions of proposed REMS
- describes each potential element
- includes preliminary information on the content of assessments and proposed modifications of approved REMS
- describes REMS policies for certain regulatory situations
- informs industry about who to contact within FDA about a REMS
- indicates FDA Web sites where documents about approved REMS will be posted
- provides an example of what an approved REMS might look like for a fictitious product.
"With this new guidance, manufacturers will have a useful blueprint for how to develop these important safety strategies," said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research.
The draft guidance is available at
Future draft guidances will address additional REMS topics.
Media Inquiries: Karen Riley, 301-796-4674, firstname.lastname@example.org
Consumer Inquiries: 888-INFO-FDA
SOURCE U.S. Food and Drug Administration
Related medicine news :1
|SOURCE U.S. Food and Drug Administration|
Copyright©2009 PR Newswire.
All rights reserved
. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues2
. PowerBar Issues Open Call for 2008-2009 PowerBar Team Elite(TM) Athlete Sponsorship Program3
. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.4
. American Red Cross Issues Blood Supply Alert5
. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards6
. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues7
. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions8
. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues9
. Dallas-Area Transplant Meeting Puts Spotlight on Key Issues10
. Elder Care Author Doctor Marion Launches Second National Tour to Raise Awareness About Aging & Elder Care Issues in America11
. California State PTA Issues Statement Regarding Presidents Veto of SCHIP Legislation